Cue Biopharma (CUE) Asset Utilization Ratio (2018 - 2025)
Cue Biopharma (CUE) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.41 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio rose 68.66% to 0.41 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.41 through Dec 2025, up 68.66% year-over-year, with the annual reading at 0.74 for FY2025, 272.53% up from the prior year.
- Asset Utilization Ratio hit 0.41 in Q4 2025 for Cue Biopharma, up from 0.2 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.41 in Q4 2025 to a low of 0.0 in Q1 2023.
- Historically, Asset Utilization Ratio has averaged 0.14 across 5 years, with a median of 0.13 in 2022.
- Biggest five-year swings in Asset Utilization Ratio: tumbled 96.98% in 2023 and later surged 2333.89% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.18 in 2021, then tumbled by 91.93% to 0.01 in 2022, then surged by 466.62% to 0.08 in 2023, then soared by 186.51% to 0.24 in 2024, then soared by 68.66% to 0.41 in 2025.
- Business Quant data shows Asset Utilization Ratio for CUE at 0.41 in Q4 2025, 0.2 in Q3 2025, and 0.26 in Q2 2025.